136 related articles for article (PubMed ID: 11490856)
1. Comparison between pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer.
Yoshimi F; Asato Y; Amemiya R; Shioyama Y; Itabashi M
Hepatogastroenterology; 2001; 48(40):994-8. PubMed ID: 11490856
[TBL] [Abstract][Full Text] [Related]
2. Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer.
Kaneoka Y; Yamaguchi A; Isogai M
J Hepatobiliary Pancreat Surg; 2007; 14(2):142-8. PubMed ID: 17384904
[TBL] [Abstract][Full Text] [Related]
3. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
[TBL] [Abstract][Full Text] [Related]
4. Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy?
Miwa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Ogawa S; Soeda J; Miyagawa S
J Hepatobiliary Pancreat Surg; 2007; 14(2):136-41. PubMed ID: 17384903
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
[TBL] [Abstract][Full Text] [Related]
6. An experience of hepatopancreatoduodenectomy in patients with hepatobiliary malignancies.
Nanashima A; Nagasaki T; Sumida Y; Abo T; Tobinaga S; Takeshita H; Nonaka T; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(86-87):1691-4. PubMed ID: 19102371
[TBL] [Abstract][Full Text] [Related]
7. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract.
Nimura Y; Hayakawa N; Kamiya J; Maeda S; Kondo S; Yasui A; Shionoya S
Hepatogastroenterology; 1991 Apr; 38(2):170-5. PubMed ID: 1649788
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan--experience of a single institute.
Suzuki M; Unno M; Oikawa M; Endo K; Katayose Y; Matsuno S
Hepatogastroenterology; 2000; 47(33):650-7. PubMed ID: 10919005
[TBL] [Abstract][Full Text] [Related]
9. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients.
Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
Ann Surg; 2012 Aug; 256(2):297-305. PubMed ID: 22750757
[TBL] [Abstract][Full Text] [Related]
10. [Indication and outcome of extended right hemihepatectomy combined with pancreatoduodenectomy for bile duct carcinoma].
Noie T; Seyama Y; Imamura H; Kobayashi A; Miyagawa S; Kawasaki S; Makuuchi M
Nihon Geka Gakkai Zasshi; 2001 Feb; 102(2):215-9. PubMed ID: 11260903
[TBL] [Abstract][Full Text] [Related]
11. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis.
Varotti G; Gondolesi GE; Roayaie S; Suriawinata A; Soltys K; Fishbein TM; Schwartz ME; Miller C
J Am Coll Surg; 2003 Nov; 197(5):765-9. PubMed ID: 14585411
[TBL] [Abstract][Full Text] [Related]
12. Role of hepatectomy in the treatment of hilar bile duct carcinoma.
Tsuchikawa T; Kondo S; Hirano S; Tanaka E; Anbo Y; Morikawa T; Okushiba S; Katoh H
Surg Today; 2004; 34(5):405-8. PubMed ID: 15108077
[TBL] [Abstract][Full Text] [Related]
13. Extrahepatic bile duct carcinoma: a western experience with 118 consecutive patients.
Doglietto GB; Alfieri S; Pacelli F; Mutignani M; Costamagna G; Carriero C; Di Giorgio A; Papa V
Hepatogastroenterology; 2000; 47(32):349-54. PubMed ID: 10791187
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for radical resection of middle and distal bile duct cancer.
Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
[TBL] [Abstract][Full Text] [Related]
16. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
17. [Combined total hepatectomy, orthotopic liver transplantation and pancreatoduodenectomy for unresectable hilar bile duct carcinoma].
He XS; Zhang S; Zhu XF; Ji Y; Zeng JX; Ma Y; Wang DP; Ju WQ; Wu LW; Li Z; Huang JF
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):302-5. PubMed ID: 16635386
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of resection and intraoperative radiation for patients with carcinomas of extrahepatic bile duct and ampulla of Vater: prognostic advantage over resection alone?
Nakano K; Chijiiwa K; Toyonaga T; Ueda J; Takamatsu Y; Kimura M; Nakamura K; Yamaguchi K; Tanaka M
Hepatogastroenterology; 2003; 50(52):928-33. PubMed ID: 12845952
[TBL] [Abstract][Full Text] [Related]
19. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
